Cargando…
Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo
BACKGROUND AND METHODS: Paclitaxel, a widely used antitumor agent, has limited clinical application due to its hydrophobicity and systemic toxicity. To achieve sustained and targeted delivery of paclitaxel to tumor sites, liposomes composed of egg phosphatidylcholine, cholesterol, and distearolyphos...
Autores principales: | Cai, Lulu, Wang, Xianhuo, Wang, Wenwen, Qiu, Neng, Wen, Jiaolin, Duan, Xingmei, Li, Xia, Chen, Xiang, Yang, Li, Qian, Zhiyong, Wei, Yuquan, Chen, Lijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423151/ https://www.ncbi.nlm.nih.gov/pubmed/22923988 http://dx.doi.org/10.2147/IJN.S32817 |
Ejemplares similares
-
Improving aqueous solubility and antitumor effects by nanosized gambogic acid-mPEG(2000) micelles
por: Cai, Lulu, et al.
Publicado: (2013) -
Honokiol Crosses BBB and BCSFB, and Inhibits Brain Tumor Growth in Rat 9L Intracerebral Gliosarcoma Model and Human U251 Xenograft Glioma Model
por: Wang, Xianhuo, et al.
Publicado: (2011) -
A Novel PEGylated Liposome-Encapsulated SANT75 Suppresses Tumor Growth through Inhibiting Hedgehog Signaling Pathway
por: Yuan, Yike, et al.
Publicado: (2013) -
Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2‐overexpressing tumor
por: Kuroda, Kenji, et al.
Publicado: (2020) -
Peg-Grafted Liposomes for L-Asparaginase Encapsulation
por: de Souza Guimarães, Marina, et al.
Publicado: (2022)